Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives. Issue 10 (2nd October 2016)

• Record Type: Journal Article
• Authors: Agénor, Madina; Peitzmeier, Sarah M.; Bernstein, Ida M.; McDowell, Michal; Alizaga, Natalie M.; Reisner, Sari L.; Pardee, Dana J.; Potter, Jennifer
• Is Part Of: Culture, health & sexuality. Volume 18:Issue 10(2016)
• Page Start: 1192
• Page End: 1206
• Publication Date: 2016-10-02
• Subjects: Transgender -- transmasculine -- healthcare providers -- cervical cancer -- risk perceptions -- USA; Sex -- Periodicals; Sex -- Cross-cultural studies -- Periodicals; Sex -- Health aspects -- Periodicals; 306.705
• DOI: 10.1080/13691058.2016.1177203
• Languages: English
• ISSNs: 1369-1058

Abstract

Abstract: Transmasculine people (individuals assigned a female sex at birth who identify as male or masculine) are at risk of cervical cancer. Despite low rates of Pap test use in this population, research examining the determinants of cervical cancer screening among transmasculine individuals is scarce. We conducted in-depth interviews and focus groups with 49 participants (32 transmasculine patients and 17 healthcare providers) in order to examine transmasculine individuals' and healthcare providers' perceptions of cervical cancer risk and screening among individuals on the transmasculine continuum. Overall, patients believed that transmasculine individuals should receive regular Pap tests, especially in the event of gynaecological concerns. While healthcare providers' views varied, many perceived transmasculine individuals to be at low risk of cervical cancer. Contrary to existing screening guidelines, several providers believed that transmasculine individuals who did not engage in penile-vaginal intercourse with cisgender men, expressed discomfort about Pap testing or intended to obtain a hysterectomy might not need to be screened regularly or at all. Our findings underscore the importance of educating patients and providers about cervical cancer risk among transmasculine individuals and establishing evidence-based guidelines for cervical cancer screening in this underserved population.